Trends in survival of patients with metastatic breast cancer [14]

Journal of Clinical Oncology

Volumn 23, Issue 9, 2005, Pages 2116-

  Voogd, Adri C ^a   van Gestel, Kitty ^a   Ernst, Miranda F ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATASE INHIBITOR; TAXANE DERIVATIVE;

BLOOD EXAMINATION; BONE METASTASIS; BONE SCINTISCANNING; BREAST CANCER; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; DISEASE COURSE; HUMAN; LETTER; LIFE EXPECTANCY; MAMMOGRAPHY; PHYSICAL EXAMINATION; PLEURA EFFUSION; PLEURODESIS; PRIORITY JOURNAL; SURVIVAL RATE; THORAX RADIOGRAPHY; BREAST TUMOR; FEMALE; METASTASIS; MORTALITY; NOTE; PATHOLOGY; REGISTER;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASM METASTASIS; REGISTRIES; SURVIVAL RATE;

EID: 15744402674     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.05.254     Document Type: Letter

References (2)

1. Andre F, Slimane K, Bachelot T, et al: Breast cancer with synchronous metastases: Trends in survival during a 14-year period. J Clin Oncol 22:3302-3308, 2004
2. Coebergh JWW, Janssen-Heijnen MLG, Louwman WJ, et al (eds): Cancer incidence, care and survival in the South of the Netherlands, 1955-1999: A report of the Eindhoven Cancer Registry with cross-border implications. Eindhoven, the Netherlands: Comprehensive Cancer Centre South (IKZ), 2001